06/17/2014 - 1:59pm

"Some suggest that the art of effective communication has been lost forever. We are living in a world of instantaneous, rapid-fire communication. I fear that our desire to respond rather than reflect has resulted in a society that spends more time trying to clarify rather than progressing," writes Dave Wendland, Hamacher Resource Group VP, in his latest blog entry.

06/17/2014 - 1:07pm

The American Diabetes Association will lower its target recommendation for blood glucose levels for children with Type 1 diabetes, according to a statement released at the association's 74th Scientific Sessions.

06/17/2014 - 12:52pm

Drchrono, a creator of a free electronic health record platform on the iPad, iPhone and cloud, has integrated Google Glass into its EHR platform to build the first wearable health record for physicians.

06/17/2014 - 12:43pm

The California Department of Public Health announced that the number of pertussis (whooping cough) cases in the state has become an epidemic, with 3,458 cases of pertussis reported since June 10.

06/17/2014 - 12:24pm

Walmart, Costco, Walgreens, FreshDirect, CVS and drugstore.com have reached an agreement with the New York State Attorney General to provide unit pricing information on their websites and mobile apps.

06/17/2014 - 12:22pm

Novartis on Tuesday announced that it had submitted a biologic license application to the Food and Drug Administration for marketing approval for the use of Bexsero.

06/17/2014 - 12:12pm

Global design company Threadless is partnering with Recycled Paper Greetings to bring Threadless' community-driven artwork to national retailers through a new line of greeting cards, which showcase the talents of 61 artists from 18 countries.

06/17/2014 - 12:06pm

More than half of consumers check to see if the products they are buying are "natural," despite there being no federal or third-party verified label for this term, according to a new national survey by the Consumer Reports National Research Center.

06/17/2014 - 11:55am

Lannett Co. received approval from the Food and Drug Administration for codeine sulfate tablets USP, a schedule II controlled substance, in 15 mg, 30 mg and 60 mg dosage strengths.